A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2021.11.25.21266704: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The study protocol was approved by the local Ethics Committee (comité de protection des personnes de Strasbourg, France, identifier: DC-2013– 1990) and written informed consent was obtained from participants.
Consent: The study protocol was approved by the local Ethics Committee (comité de protection des personnes de Strasbourg, France, identifier: DC-2013– 1990) and written informed consent was obtained from participants.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources Anti-IgG antibody titers were measured with an ARCHITECT IgG II Quant test (Abbott, Abbott Park, IL, USA; … SciScore for 10.1101/2021.11.25.21266704: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The study protocol was approved by the local Ethics Committee (comité de protection des personnes de Strasbourg, France, identifier: DC-2013– 1990) and written informed consent was obtained from participants.
Consent: The study protocol was approved by the local Ethics Committee (comité de protection des personnes de Strasbourg, France, identifier: DC-2013– 1990) and written informed consent was obtained from participants.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources Anti-IgG antibody titers were measured with an ARCHITECT IgG II Quant test (Abbott, Abbott Park, IL, USA; assay range: 1–11360 binding antibody units [BAUs]/mL). Anti-IgGsuggested: NoneSoftware and Algorithms Sentences Resources Anti-IgG antibody titers were measured with an ARCHITECT IgG II Quant test (Abbott, Abbott Park, IL, USA; assay range: 1–11360 binding antibody units [BAUs]/mL). Abbottsuggested: (Abbott, RRID:SCR_010477)All calculations were performed using GraphPad Prism, version 8.0 (GraphPad Inc., San Diego, CA, USA). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-